WS12-3 Real-world outcomes among patients with cystic fibrosis treated with lumacaftor/ivacaftor (LUM/IVA) in 2017: an interim analysis of data from the US CF Foundation Patient Registry (CFFPR)
| Autor: | S. Tian, C. Knox, L.T. Wang, A. Elbert, R. Wu, Z. Han |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
Pulmonary and Respiratory Medicine
Pediatrics medicine.medical_specialty Patient registry business.industry Lumacaftor Real world outcomes Foundation (evidence) Interim analysis medicine.disease Cystic fibrosis Ivacaftor chemistry.chemical_compound chemistry Pediatrics Perinatology and Child Health Medicine business medicine.drug |
| Zdroj: | Journal of Cystic Fibrosis. 18:S22-S23 |
| ISSN: | 1569-1993 |
| DOI: | 10.1016/s1569-1993(19)30188-2 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect